EUROPEAN, COMMISSION

EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS

Published on 03/17/2026 at 17:29 | prnewswire.co.uk

Amgen California

View original content:https://www.prnewswire.co.uk/news-releases/european-commission-approves-amgens-uplizna-for-generalized-myasthenia-gravis-302686432.html

en | boerse | 68714077 |